Health
Epic Systems expands EHR market share lead over Oracle Health
The eponymous sign outside Epic headquarters in Verona, Wisconsin. Source: Yiem via Wikipedia CC Epic Systems, the biggest electronic health records (EHR) vendor, notched its largest ever net gain in hospital market share on record in 2024, widening its lead over rival Oracle, according to a report from Klas Research on Wednesday. Epic added a […]
Read More
Teladoc buys mental health company UpLift to help boost struggling BetterHelp unit
Teladoc Health Inc. signage on the floor of the New York Stock Exchange on Dec. 31, 2024. Michael Nagle | Bloomberg | Getty Images Virtual care provider Teladoc Health, which has seen its market value plummet over the past five years, said Wednesday that it acquired mental health company UpLift for $30 million in cash. […]
Read More
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Jgi/jamie Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Tariff threats — and efforts to get into President Donald Trump’s good graces — are fueling a new wave […]
Read More
RFK Jr. is gutting minority health offices across HHS that are key to reducing health disparities
Employees of the Department of Health and Human Services (HHS) queue outside the Mary E. Switzer Memorial Building, after it was reported that the Trump administration fired staff at the Centers for Disease Control and Prevention and at the Food and Drug Administration, as it embarked on its plan to cut 10,000 jobs at HHS, […]
Read More
GE HealthCare beats on earnings, slashes full year outlook due to tariffs
GE HealthCare reported better-than-expected first-quarter results on Wednesday, but the company slashed its annual forecast to account for the impact of President Donald Trump’s far-reaching “reciprocal” tariff policy. Shares of GE HealthCare were up 3% on Wednesday. Here’s how the company did: Earnings per share: $1.01 adjusted vs. 91 cents expected by LSEG. Revenue: $4.78 […]
Read More
GLP-1s can help employers lower medical costs in 2 years, new study finds
Packages of weight loss drugs Wegovy, Ozempic and Mounjaro. Picture Alliance | Getty Images The growing demand for diabetes and weight loss drugs like Mounjaro, Ozempic and Wegovy has helped fuel higher health costs for large employers. For many, the big question is whether the pricy medications known as GLP-1s will pay off by improving […]
Read More
The outdated health idea that’s holding women back in life and careers
Twenty-five years ago, Joanna Strober invested in a company called BabyCenter. Twenty-five years later, the company is still serving women, “a lot of women,” Strober says. She was a pregnant venture investor at the time she made the BabyCenter investment, and it helped to spark a bigger idea: for too long, she says, the storyline […]
Read More
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York City, U.S., May 22, 2024. Andrew Kelly | Reuters Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and […]
Read More
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 30%
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images Novo Nordisk on Tuesday said it will offer its weight loss drug Wegovy through telehealth providers Hims & Hers Health, Ro and […]
Read More
Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall
The Pfizer logo is seen outside the pharmaceutical company’s manufacturing plant, in Newbridge, Ireland February 10, 2025. Clodagh Kilcoyne | Reuters Pfizer on Tuesday expanded its cost-cutting efforts and reported first-quarter profit that topped estimates, even as the company’s sales fell, largely due to dwindling revenue for its antiviral Covid pill Paxlovid. The company previously […]
Read More